| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |